InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,648.40
(
1.01%
)
US TECH 100
19,050.40
(
1.19%
)
Dow Jones
41,563.08
(
0.55%
)
Brent Oil
77.00
(
0.00%
)
Bitcoin
59,201.21
(
0.15%
)
Post# of 252997
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 837
Posts 120350
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 182185

Wednesday, 02/04/2015 11:28:03 AM

Wednesday, February 04, 2015 11:28:03 AM

Post# of 252997
AMGN reports positive phase-3 data for Humira FoB in RA:

http://finance.yahoo.com/news/amgen-announces-positive-top-line-210100426.html

Note: AMGN is partnered with ACT on FoBs for oncology (#msg-70097496), but not on the Humira FoB.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up